Indaptus Therapeutics extends $24.0 million private placement closing deadline to October 16, 2026
Indaptus Therapeutics agreed on September 29, 2026 to extend the outside date for the closing of its $24.0 million private placement of common stock from September 29 to October 16, 2026. The notices and consents also let the company defer closing until purchaser closing conditions are met or waived, and extend the purchasers' funding deadline and related termination rights to the same date. For shareholders, the filing shows the financing has not yet closed and its timing now depends on the extended deadline.
Key points
- Private placement of common stock with aggregate gross proceeds of approximately $24.0 million, before offering expenses, agreed on September 8, 2026
- Outside date extended from September 29, 2026 to October 16, 2026 for each purchaser
- Company may defer closing until purchaser closing conditions are satisfied or waived, but no later than October 16, 2026, unless otherwise agreed in writing
- All other terms of the Purchase Agreement remain unchanged
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.